2696 — Shanghai Henlius Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Shanghai Henlius Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,305	1,114	707	841	988
Net Total Accounts Receivable
Net Total Receivables	148	402	429	508	865
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,661	1,910	1,647	2,192	2,676
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	857	1,437	1,667	2,230	2,653
Net Intangible Assets
Other Long Term Assets
Total Assets	5,900	6,439	7,173	8,924	9,904
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	960	1,980	2,960	5,002	5,067
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,899	3,240	4,876	7,288	7,711
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4,000	3,199	2,297	1,636	2,192
Total Liabilities & Shareholders' Equity	5,900	6,439	7,173	8,924	9,904
Total Common Shares Outstanding